The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models
Article in Biomedicine & Pharmacotherapy (March 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Thylakoid supplementation and hunger and fullness perception: a systematic review and dose-response meta-analysis of randomized controlled trials
Article in Nutrition Reviews (March 2024)
Exploring the Therapeutic Potential of Natural Products in Polycystic Ovarian Syndrome (PCOS): A Mini-Review of Lipid Profile, Blood Glucose, and Ovarian Histological Improvements
Article in Life (January 2024)